Clinical Trial Update: Telitacicept for PGNMID: A Single-Arm Study [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 single-arm clinical trial evaluating Telitacicept for Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Peking University First Hospital | Conditions: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits | Phase 2 | Status: ACTIVE_NOT_RECRUITING